Recursion Pharmaceuticals Inc News - RXRX | ADVFN

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Recursion Pharmaceuticals Inc (RXRX)
Recursion Pharmaceuticals Inc (RXRX) News

Recursion Pharmaceuticals Inc (RXRX)

6.53

0.13

(2.03%)

Closed January 17 4:00PM

Delayed by 15 minutes

6.76

0.23

( 3.52% )

Pre Market: 5:40AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Form 8-K/A - Current report: [Amend]

Form 8-K/A - Current report: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

1
2
3
Next

bwrbad

bwrbad 1 day ago

bwrbad

bwrbad 6 days ago

believe in miracle ----- come to RXRX------

TucsonPhil

TucsonPhil 1 week ago

Looks like Lilly is late to the party.

https://www.statnews.com/2025/01/10/eli-lilly-andreessen-horowitz-500-million-venture-fund-ai-focus/

bwrbad

bwrbad 2 weeks ago

cursion-re-cursion in flame after FDA REC 3565 blessings

bwrbad

bwrbad 2 weeks ago

Gibson🤢🥵🥶😷Gibson

bwrbad

bwrbad 3 weeks ago

bwrbad

bwrbad 3 weeks ago

balding haircut at RXRX

Monksdream

Monksdream 4 weeks ago

bwrbad

bwrbad 1 month ago

out for now, let CEO work his magic if he has one under his sleeve

bwrbad

bwrbad 1 month ago

is something wrong with RxRx, it looked promising based on what said to public. but something not right. ground shaken up. - like trouble.
what wrong with the CEO. if this continues that is bad sign for future of the company and the CEO.

bwrbad

bwrbad 1 month ago

bwrbad

bwrbad 1 month ago

RxRx partnership: GOOG NVDA MSFT Roche/Genentech Bayer Bristol Myers Squibb Sanofi Merck ......

bwrbad

bwrbad 1 month ago

RxRx M&A: Valence –Cyclica - Exscientia
Valence – a leader in generative AI and deep learning models
Cyclica - a deep learning engine that predicts the polypharmacology of small molecules in drug discovery.
Exscientia - AI-driven precision medicine
RXRX - Regenerative AI - TechBio powerhouse
undergoing post merger reorganization, some job cuts
enough cash to fund through 2027
Ark Q3 2024 Stake: $215.9 million
Hedge Fund Investors Q3 2024:: 16
more than ten drugs in trials.

bwrbad

bwrbad 1 month ago

market up big and RxRx ignored,
if quantum computing which is 7-10 years away getting attention now, then this should be in the rocket heading for stratosphere.

TucsonPhil

TucsonPhil 1 month ago

RXRX seeing some promising results in early trials. Proof of concept will solidify belief in the platform.

If cost of trials can be reduced, by less attrition of candidates, then they should see more licensing agreements, and funding, from pharma companies IMO.

bwrbad

bwrbad 1 month ago

Revenue (ttm) 65.18M; Quarterly Revenue Growth (yoy) 147.60%
Total Cash (mrq) 427.65M; Total Debt (mrq) 90.62M
Shares Outstanding 6 388.94M; Float 8 252.42M
clinical trial : REC-994 in Phase 2, REC-2282 in Phase 2/3; few other in phase 1 and 2, all in less than 2 year not 15-18 years (conventional).

% Held by Institutions 1 69.40% Shares Short (Nov 15, 2024) 4 64.57M 25%

JJ8

JJ8 1 month ago

Rxrx share price Long Tail Up since 06 Dec 2024.

paperman

paperman 1 month ago

Phase 1 news expected tonight at conference.

paperman

paperman 1 month ago

Phase 1 news expected tonight at conference.

bwrbad

bwrbad 1 month ago

this is one magnificent AI drug discovery platform - be household name like google tesla Microsoft ...

JJ8

JJ8 2 months ago

Bought it yesterday at $6.60

Today it's up about 22%.

Same story with 2 other stocks and they all go up today more than 20%!

Whoa! IN CREDIBLE!

TucsonPhil

TucsonPhil 2 months ago

Agreed, but there will be wild swings, until they get their footing with clinical trials proving the concept works. Trade it until then, and keep one foot in the door for surprise announcements.

bwrbad

bwrbad 2 months ago

RxRx going to be top player in future pharma drug discovery

TucsonPhil

TucsonPhil 2 months ago

Good company, but MMs playing games this morning. Insider buying? News? Who knows? Missed this runup, but will wait for the dip again.

bwrbad

bwrbad 2 months ago

GOOG -- RxRx -- NVDA -- RxRx -- MSFT

bwrbad

bwrbad 2 months ago

agree but better, much bigger scope, on way to become a high flying company of the future
price target 150 in two year

uksausage

uksausage 2 months ago

no it is the PLTR of Drug discovery
both rely on NVDA to run fast

bwrbad

bwrbad 2 months ago

started buying little little- this is NVDA of DRUG DISCOVERY

ToucanYoucan

ToucanYoucan 2 months ago

$RXRX - That's why I'm planning to steadily accumulate shares - with the hope that one or more of these new treatments materializes.

bwrbad

bwrbad 2 months ago

high potential if delivers,

TucsonPhil

TucsonPhil 2 months ago

Good gains in past week, but looks like it is getting ready to drift lower again.

TucsonPhil

TucsonPhil 2 months ago

First patient dosed.

https://ir.recursion.com/news-releases/news-release-details/recursion-announces-first-patient-dosed-phase-12-clinical-study

lambchops

lambchops 2 months ago

Glad to see the uptick! Was beaten down for a while. Too good of stock to be down for long.

LC

RXRX

ToucanYoucan

ToucanYoucan 2 months ago

$RXRX - Having a huge day here!!

ToucanYoucan

ToucanYoucan 2 months ago

$RXRX - Nice move up today! This will take a little time to find its footing pps-wise after the merger...imo

TucsonPhil

TucsonPhil 2 months ago

Many foreign countries supplying pharmaceuticals to U.S. at exorbitant markups.

Will anything be done about that? I do not believe tariffs will help with that problem, since people either pay, whatever the cost, or suffer and die.

Monksdream

Monksdream 3 months ago

Monksdream

Monksdream 3 months ago

Monksdream

Monksdream 3 months ago

mick

mick 3 months ago

abrooklyn

abrooklyn 4 months ago

https://x.com/RecursionPharma/status/1841453309342740925

TucsonPhil

TucsonPhil 4 months ago

So many clinical trials in work, but for this to translate to value, they will need to show high efficacy and a much shorter time-to-market, using Recursion platform. The problem may be that Recursion can identify promising candidates quickly, but the slow-moving follow-on processes will still eat up valuable time. The value proposition here is the decrease in attrition, for candidates that fail in early stage trials.

https://ir.recursion.com/news-releases/news-release-details/recursion-gives-guidance-seven-clinical-readouts-within-18

https://www.recursion.com/pipeline

mick

mick 4 months ago

WALL @ $7.5 , $7.0

mick

mick 4 months ago

https://www.stockscores.com/charts/charts/?ticker=RXRX

lambchops

lambchops 4 months ago

Yes. Good stock to put on watchlist IMO.
Still reasonably cheap. Check MACD.

LC

RXRX

mick

mick 4 months ago

diamond in the ruff

RXRX
Recursion Pharmaceuticals Inc
6.32
0.20 (3.27%)
Volume: 3,082,418
Day Range: 6.055 - 6.32
Last Trade Time: 4:28:47 PM EDT

mick

mick 4 months ago

RXRX
Recursion Pharmaceuticals Inc
5.95
-0.22 (-3.57%)
Volume: 4,577,882
Day Range: 5.895 - 6.30
Last Trade Time: 7:58:59 PM EDT

lambchops

lambchops 4 months ago

Yes, I've been adding shares of RXRX this week.

LC

RXRX

TucsonPhil

TucsonPhil 5 months ago

Looks.like a little dilution, but a good buying opportunity, to add some more.

lambchops

lambchops 5 months ago

Judging on the reaction some investors must not have liked it either.Will be a strong company into RXRX.I like buying good companies that have a downdraft. They usually come back strong.
Please note I own shares in this company.

LC

RXRX

Recursion Pharmaceuticals

Delayed Upgrade Clock